Indeed, several IBD risk loci can modulate T cell function, with at least 24 variants being implicated within the Th17 cell regulatory network, such as STAT3, IL23R, CCR6, AHR and CCL2 (3, 24, 26). The gene discussed is STAT3; the disease is inflammatory bowel disease.